Hepatocellular Carcinoma clinical trials
Access comprehensive clinical trial information for Hepatocellular Carcinoma through Pure Global AI's free database. This collection includes 1,119 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 339 trials are actively recruiting participants.
Research for Hepatocellular Carcinoma is being conducted in China, United States of America, South Korea and 7+ other countries. Leading sponsors include Sun Yat-sen University and Eastern Hepatobiliary Surgery Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 1,119 clinical trials studying Hepatocellular Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Sun Yat-sen University, Eastern Hepatobiliary Surgery Hospital, Fudan University, among others.